SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
32 hedge funds and large institutions have $6.12M invested in Sigilon Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
5
Reduced
9
Closed
5
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$2K
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$11.7K |
2 |
2
Renaissance Technologies
New York
|
$65K |
3 |
VF
3
Virtu Financial
New York
|
$4K |
4 |
4
Millennium Management
New York
|
$81K |
5 |
5
BlackRock
New York
|
$372K |